Clinical Trials Directory

Trials / Completed

CompletedNCT00143260

Study Of Men With Mild To Moderate Erectile Dysfunction To Evaluate The Efficacy Of Viagra 8 Hours Post-Dose

Multicenter Randomized Double-Blind, Placebo-Controlled, Fixed-Dose Parallel Study Of Men With Mild To Moderate Erectile Dysfunction To Evaluate The Efficacy Of Viagra 8 Hours Post-Dose - II

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
250 (planned)
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
Sex
Male
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Safety/Efficacy of 100mg Viagra at 8 hours post dose in men with mild to moderate erectile dysfunction

Conditions

Interventions

TypeNameDescription
DRUGViagra (Sildenafil Citrate) 100 mg

Timeline

Start date
2005-08-01
Primary completion
2006-05-01
Completion
2006-05-01
First posted
2005-09-02
Last updated
2021-02-01

Locations

25 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00143260. Inclusion in this directory is not an endorsement.